ArticleClinical research in cardiology : official journal of the German Cardiac Society2026
Safety and efficacy of thrombolysis with the EkoSonic Endovascular System for intermediate-high risk pulmonary embolism during on- and off-hours: a multicenter study.
Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early versus delayed EKOS thrombolysis in intermediate-high risk pulmonary embolism: a retrospective multicentre analysis.Open heart · 2026Article
- Safety and Efficacy of Ultrasound-Accelerated Endovascular Lysis in Postoperative Patients with Intermediate-High-Risk Pulmonary Embolism: A Retrospective Two-Center Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCatheter-directed thrombolysis using the EkoSonic™ Endovascular System (EKOS) is an established therapy for intermediate-high risk (IHR) pulmonary embolism (PE). However, whether the timing of intervention, during regular working hours (RW) versus (vs.) on duty hours (OD), impacts safety and efficacy outcomes remains unclear.
methodsWe retrospectively analyzed consecutive patients with IHR-PE treated with EKOS-lysis at three German centers between 08/2020 and 12/2023. Patients were grouped by timing into RW and OD group, based on institutional definitions of working hours. The primary endpoint was procedural safety, including in-hospital mortality of any cause and bleeding/non-bleedings complications. Secondary outcome compromised echocardiographic efficacy parameters, including reduction in right ventricular to left ventricular (RV/LV) ratio, systolic pulmonary artery pressure (sPAP), and improvement in tricuspid annular plane systolic excursion (TAPSE).
resultsOf 154 patients, 99 procedures were performed during RW hours, while 55 were done during OD hours. Baseline characteristics were comparable in both groups. Door-to-EKOS time (20.6 (4.8; 44) h vs. 7.2 (4,1; 19) h; p = 0.012) and CT-EKOS time (6.4 (1.3; 20) h vs. 2.3 (1.4; 3.5) h; p = 0.002) were significantly shorter during OD. Overall complication rates were lower OD (20 (20.2%) vs. 4 (7.3%); p = 0.038), with fewer bleeding events (18 (18.2%) vs. 3 (5.5%); p = 0.029). In-hospital mortality was similar (RW 8 (8.1%) vs. OD 2 (3.6%); p = 0.496). Both groups showed significant improvement in echocardiographic parameters with no significant intergroup differences in treatment efficacy.
conclusionEKOS-lysis performed during OD hours is safe and effective, with even fewer complications than during RW hours. These findings support the feasibility and safety of continuous PE-care by an experienced Pulmonary Embolism Response Team irrespective of procedural timing.
Indexed as
Identifiers
41396305What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.